2024
Blood type as a risk factor for pancreatic ductal adenocarcinoma.
Rahimi Larki N, Skanderson M, Tate J, Levinson R, Hauser R, Brandt C, Yang Y, Justice A, Wang L. Blood type as a risk factor for pancreatic ductal adenocarcinoma. Journal Of Clinical Oncology 2024, 42: 10559-10559. DOI: 10.1200/jco.2024.42.16_suppl.10559.Peer-Reviewed Original ResearchPancreatic ductal adenocarcinoma riskVeterans Health AdministrationRisk of pancreatic ductal adenocarcinomaNon-O blood typeNeighborhood-level socioeconomic dataIntegrated healthcare systemHigh risk of pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaAssociated with higher riskAssociated with increased riskUnited StatesHealth AdministrationOutpatient encountersHealthcare systemBaseline ageAlcohol useIndex dateAssociation of blood typeCancer deathWhite populationSocioeconomic dataBlack patientsDiverse populationsRisk factorsBlood type
2022
Graphical analysis of guideline adherence to detect systemwide anomalies in HIV diagnostic testing
Hauser RG, Bhargava A, Brandt CA, Chartier M, Maier MM. Graphical analysis of guideline adherence to detect systemwide anomalies in HIV diagnostic testing. PLOS ONE 2022, 17: e0270394. PMID: 35776743, PMCID: PMC9249187, DOI: 10.1371/journal.pone.0270394.Peer-Reviewed Original ResearchConceptsHIV diagnostic testingHIV testingDiagnostic testingGuideline recommendationsClinical practiceHIV nucleic acid testHIV resistance testsElectronic medical databasesNucleic acid testDiagnostic testing guidelinesDiagnostic test resultsDelay careGuideline adherenceHIV transmissionDiagnostic workupHIV screenNational healthcare systemPractice deviationsHIV detectionTesting guidelinesComplex medical scenariosIntervention targetsMedical databasesHealthcare systemAcid test